

Lead Product(s) : Carotenoid
Therapeutic Area : Undisclosed
Study Phase : Undisclosed
Sponsor : MacuHealth
Deal Size : Inapplicable
Deal Type : Inapplicable
Carotenoid Supplementation and Retinal Health in Healthy Adults
Details : Carotenoid is a plant extract/herbal drug, which is currently being evaluated in clinical studies for the treatment of undefined medical condition.
Product Name : Undisclosed
Product Type : Plant Extract/Herbal
Upfront Cash : Inapplicable
January 02, 2026
Lead Product(s) : Carotenoid
Therapeutic Area : Undisclosed
Highest Development Status : Undisclosed
Sponsor : MacuHealth
Deal Size : Inapplicable
Deal Type : Inapplicable

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Carotenoid
Therapeutic Area : Cardiology/Vascular Diseases
Study Phase : Phase IV
Sponsor : Bio-gen Extracts
Deal Size : Inapplicable
Deal Type : Inapplicable
CaroRiteâ„¢ for Skin Health and Signs of Ageing
Details : Carotenoids is a Plant Extract/Herbal drug candidate, which is currently being evaluated in phase IV clinical studies for the treatment of Aging.
Product Name : Undisclosed
Product Type : Plant Extract/Herbal
Upfront Cash : Inapplicable
March 14, 2025
Lead Product(s) : Carotenoid
Therapeutic Area : Cardiology/Vascular Diseases
Highest Development Status : Phase IV
Sponsor : Bio-gen Extracts
Deal Size : Inapplicable
Deal Type : Inapplicable

Lead Product(s) : Carotenoid
Therapeutic Area : Undisclosed
Study Phase : Undisclosed
Sponsor : Daiken Biomedical Co., Ltd.
Deal Size : Inapplicable
Deal Type : Inapplicable
Eye and Carotenoid Augmentation Research and Evaluation (EyeCARE)
Details : Carotenoid is a Plant Extract/Herbal drug candidate, which is currently being evaluated in clinical studies for the treatment of undefined medical condition.
Product Name : Undisclosed
Product Type : Plant Extract/Herbal
Upfront Cash : Inapplicable
February 26, 2025
Lead Product(s) : Carotenoid
Therapeutic Area : Undisclosed
Highest Development Status : Undisclosed
Sponsor : Daiken Biomedical Co., Ltd.
Deal Size : Inapplicable
Deal Type : Inapplicable

Lead Product(s) : Carotenoid
Therapeutic Area : Undisclosed
Study Phase : Undisclosed
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
A Study to Assess the Impact of a Nutritional Supplement on Wellbeing and Nutrient Absorption
Details : Carotenoid is a Plant Extract/Herbal drug candidate, which is currently being evaluated in clinical studies for the treatment of undefined medical condition.
Product Name : Undisclosed
Product Type : Plant Extract/Herbal
Upfront Cash : Inapplicable
December 27, 2024
Lead Product(s) : Carotenoid
Therapeutic Area : Undisclosed
Highest Development Status : Undisclosed
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable

Lead Product(s) : Carotenoid
Therapeutic Area : Trauma (Emergency, Injury, Surgery)
Study Phase : Phase I
Sponsor : MacuHealth | Orlando Regional Medical Center
Deal Size : Inapplicable
Deal Type : Inapplicable
Carotenoids for Collision Athletes
Details : Carotenoid is a Plant Extract/Herbal drug candidate, which is currently being evaluated in phase I clinical studies for the treatment of Craniocerebral Trauma.
Product Name : Undisclosed
Product Type : Plant Extract/Herbal
Upfront Cash : Inapplicable
February 21, 2024
Lead Product(s) : Carotenoid
Therapeutic Area : Trauma (Emergency, Injury, Surgery)
Highest Development Status : Phase I
Sponsor : MacuHealth | Orlando Regional Medical Center
Deal Size : Inapplicable
Deal Type : Inapplicable

Lead Product(s) : Carotenoid
Therapeutic Area : Ophthalmology
Study Phase : Undisclosed
Sponsor : Blackmores (China) CO., Ltd
Deal Size : Inapplicable
Deal Type : Inapplicable
Effect of Carotenoids Supplementation on Visual Function in Chinese Subjects
Details : Carotenoids is a Plant Extract/Herbal drug candidate, which is currently being evaluated in clinical studies for the treatment of Vision Disorders.
Product Name : Undisclosed
Product Type : Plant Extract/Herbal
Upfront Cash : Inapplicable
October 24, 2023
Lead Product(s) : Carotenoid
Therapeutic Area : Ophthalmology
Highest Development Status : Undisclosed
Sponsor : Blackmores (China) CO., Ltd
Deal Size : Inapplicable
Deal Type : Inapplicable
